[29]
Ortiz GG, González-Usigli H, Pacheco-Moisés FP, Mireles-Ramírez MA, Sánchez-López AL, Torres-Sánchez ED, et al. Physiology and pathology of neuroimmunology: Role of inflammation in Parkinson’s Disease. Physiology and Pathology of Immunology. 2017.
[32]
Anglada-Huguet M, Vidal-Sancho L, Cabezas-Llobet N, Alberch J, Xifró X. Pathogenesis of Huntington’s Disease: How to fight excitotoxicity and transcriptional dysregulation. Huntington’s Disease-molecular pathogenesis and current models. 2017.
[33]
Thau L, Reddy V, Singh P. Anatomy, Central Nervous System. StatPearls Publishing 2022.
[40]
Silva GA. What is nanotechnology and how is it impacting neuroscience? Forbes 2021.
[42]
Berger M. Nanotechnology for neuroscience. Nanowerk 2017.
[43]
Modi G, Pillay V. Nano-Neuromedicine. World Neurology 2014.
[71]
Patil D, Nangare S, Patil G, Nerkar K, Patil G. Development of thiolated polyethylene glycol-poly (lactic-co-glycolic acid) co-polymeric nanoparticles for intranasal delivery of quetiapine: In vitro-ex vivo characterization. Int J Polym Mater 2022; 1-11.
[97]
Ray U. What are the different types of nanoparticles?. Azonano 2018.
[101]
Pitroda J, Jethwa B, Dave SKD. A Critical Review on Carbon Nanotubes. Int J Construct Res Civil Engineer 2016; 2(5): 36-42.
[104]
Staff. What Does “In the Pipeline” Mean for Pharmaceutical Companies? The Motley Staff. 2016.
[110]
WU CC. Nanoemulsions having reversible continuous and dispersed phases. Patent EP 3159012 B1, 2019.
[111]
NAM KH. Stable nanoemulsions for ultrasound-mediated drug delivery and imaging. Patent US 8709451 B2, 2014.
[112]
Narayana C. Nanoparticle composition and process thereof. Patent WO 2009/063508 A2, 2009.
[113]
Dandr F, Ruth DM, David B, Howard WL. Compositions and methods for treating neurological disorders. Patent EP 2332570 A1, 2011.
[114]
Anirban M, George F, Savita B. Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles. Patent US 8715741 B2, 2014.
[115]
Xiarong W, Hidkei K, Herman PJ, Christopher RG, Yaohong C, Yuan-Yong Y. Hairy polymeric nanoparticles with first and second shell block polymer arms. Patent US 9493601 B2, 2016.
[116]
Ryszard K, Bogumil L, Piotr K, et al. Method of manufacturing silver nanoparticles, cellulosic fibers and nanofibers containing silver nanoparticles, fibers and nanofibers containing silver nanoparticles, use of silver nanoparticles to the manufacture of cellulosic fibers and nanofibers. Patent WO 2008/100163 A1, 2008.
[117]
Sun Y-P. Fluorescent carbon nanoparticles. Patent US 7829772 B2, 2010.
[118]
Haiping H, Bud P, David RS. Composite materials with magnetically aligned carbon nanoparticles and methods of preparation. Patent US 9892835 B2, 2018.
[119]
Haiping H, Andrew WJ. Carbon nanoparticle-containing nanofluid. Patent US 7871533 B1, 2011.
[120]
Syed QB, Teddy KM. Bulk synthesis of carbon nanotubes from metallic and ethynyl compounds. Patent AU 2003/210108 B2, 2009.
[121]
Jean J, Haku Oh J, Chul Kim D. Method for producing carbon nanoparticles JP3606855B2, 2005-01-05.
[122]
Nanomaterials market size, share & trends analysis report by product (Gold, Silver, Iron, Copper), by application (Aerospace, Automotive, Medical), by region, and segment forecasts, 2021 - 2028. 2021.
[123]
Tiwari S, Kaushik A. Nano-Neurogenesis for CNS Diseases and Disorders. Frontiers in Nanotechnology 2022; 4: 42.